About the Pharmacogenomics Session
- Genetics & Genetic Engineering
- Pharmacogenetics and Genomics
- Drug Metabolism
Genomics is the study of whole genomes of organisms, and absorb elements from genetics. It uses a combination of recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyse the structure and function of genomes.
Pharmacogenomics is the study of how genes affect a person's response to drugs. This relatively new field and combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be adapt to a person's genetic makeup. It aims to develop rational means to optimize drug therapy, with respect to the patient genotype, to ensure maximum efficiency with minimal adverse effects.
Featured Speakers — Pharmacogenomics 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Pharmacogenomics Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at PDDS 2027
Why Attend the Pharmacogenomics Conference 2027
Present Your Research
Oral and poster slots for original Pharmacogenomics work, reviewed by the scientific committee.
Network Globally
Meet researchers, clinicians, and industry leaders from around the world across three days.
Learn from Keynotes
Plenary lectures from leading voices shaping Pharmacogenomics research and practice.
Hybrid Flexibility
Attend in person in Valencia or join virtually — same program, same certificate.
Join PDDS 2027 for the Pharmacogenomics track
Oral and poster slots for your work — in person in Valencia or online. Not presenting? Attend as a delegate to learn from the field.
Pharmacogenomics Conference 2027 — FAQs
What is the Pharmacogenomics track at PDDS 2027?
The Pharmacogenomics track is a dedicated stream within PDDS 2027 covering the latest research, clinical innovation, and best practice in Pharmacogenomics. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Pharmacogenomics sessions?
Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Pharmacogenomics are all welcome — whether presenting or attending.
Can I present my research in the Pharmacogenomics track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Is virtual attendance available for Pharmacogenomics sessions?
Yes. PDDS 2027 is a hybrid conference — attend the Pharmacogenomics track in person in Valencia or join live online, with on-demand access afterward.
Join the PDDS 2027 delegation
Valencia · September 13–15, 2027 · Hybrid · in-person & virtual
Attend without presenting.